Previous | Next
2011 After Propoxyphene - Alternate Pain Medications Medscape
Now that propoxyphene is unavailable, what are other options for analgesia?
Recently, Xanodyne Pharmaceuticals, Inc. agreed to withdraw propoxyphene from the market at the request of the US Food and Drug Administration (FDA). New research found that propoxyphene, which was sold under the brand names DarvonĀ®and DarvocetĀ®, was associated with cardiac toxicity (prolonged QT interval, prolonged PR interval, and widened QRS complex) even at therapeutic dosing. This article serves as a general overview of analgesics for clinicians now faced with finding alternative pain medications for their patients.
After Propoxyphene: Alternate Pain Medications
Scott Lothian, RPh
Type: Reference Material
Author/Contact: Scott Lothian
Submitted by: admin
Added: Thu May 19 2011